The Cypriot Competition Authority initiates proceedings against national pharmaceutical association for prima facie infringements of national and EU competition laws regarding fixing of prices and other trade conditions (Cyprus Pharmaceutical Association)

The Commission for the Protection of Competition announces the notification of a Statement of Objections to the Cyprus Pharmaceutical Association regarding prima facie infringements of Section 3(1)(a) of the Protection of Competition Laws of 2008 and 2014 and Article 101(1) of the Treaty for the Functioning of the European Union The Commission for the Protection of Competition (hereinafter the "CPC") following the completion of a preliminary investigation, acting under Section 17 of the Protection of Competition Laws of 2008 and 2014 (hereinafter the "Law"), unanimously decided to initiate proceedings against the Cyprus Pharmaceutical Association (hereinafter the “CPA”), regarding prima facie

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Cypriot Competition Authority, The Cypriot Competition Authority initiates proceedings against national pharmaceutical association for prima facie infringements of national and EU competition laws regarding fixing of prices and other trade conditions (Cyprus Pharmaceutical Association), 10 June 2020, e-Competitions June 2020, Art. N° 95416

Visites 123

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues